Milestone Scientific Inc. provided revenue guidance for the fourth quarter and year ended December 31, 2021. The Company anticipates revenue of over $2.6 million for the fourth quarter of 2021 compared to $2.2 million for the fourth quarter of 2020 and revenue in excess of $10 million for the fiscal year 2021 compared to revenue of $5.4 million for fiscal 2020.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6601 USD | +0.02% |
|
-3.40% | -4.32% |
Jun. 18 | Milestone Scientific Says CompuFlo Epidural System Gains Approval in Brazil | MT |
Jun. 18 | Milestone Scientific Receives Regulatory Approval to Market Compuflo Epidural System in Brazil | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.32% | 50.97M | |
+1.20% | 204B | |
+3.41% | 178B | |
+29.77% | 154B | |
+31.60% | 112B | |
+1.60% | 64.32B | |
+19.88% | 54.88B | |
-2.27% | 47.24B | |
-9.47% | 36.8B | |
-0.94% | 35.26B |
- Stock Market
- Equities
- MLSS Stock
- News Milestone Scientific Inc.
- Milestone Scientific Inc. Provides Revenue Guidance for the Fourth Quarter and Year Ended December 31, 2021